Form 4: ClearPoint Neuro Director Acquires Shares as Compensation
SEC Form 4 Filing
Director Timothy T. Richards acquired 725 shares of ClearPoint Neuro stock as compensation for director fees.
Summary
- Director Timothy T. Richards acquired 725 shares of ClearPoint Neuro common stock on January 2, 2025.
- The shares were issued as payment for director fees under the company's Non-Employee Director Compensation Plan.
- The shares were valued at $15.38 each, which was the closing price of the stock on December 31, 2024.
- Following the transaction, Mr. Richards directly owns 65,350 shares of ClearPoint Neuro stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.
Positives
- The acquisition of shares by a director demonstrates alignment of interests between management and shareholders.
- The use of stock as compensation can help conserve cash for the company.
Industry Context
This is a standard practice for compensating non-employee directors, aligning their interests with the company's performance. It is common for companies to use stock-based compensation to conserve cash and incentivize directors.
Comparison to Industry Standards
- Stock-based compensation for non-employee directors is a common practice across various industries.
- Many companies, such as Medtronic and Stryker, use a mix of cash and stock options to compensate their board members.
- The amount of stock granted is typically based on the director's role, experience, and the company's overall compensation strategy.
- The value of the stock is often tied to the company's share price, aligning director interests with shareholder value.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Closing price of ClearPoint Neuro stock used to value shares issued to director. |
| 01/02/2025 | Date of the stock acquisition by director Timothy T. Richards. |
| 01/03/2025 | Date of the Form 4 filing. |
Keywords
ClearPoint Neuro, Director Compensation, Stock Acquisition, Form 4, Insider Trading, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.